P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events

Bibliographic Details
Main Authors: G.-J. Liefers, E. Meershoek-Klein Kranenbarg, M. Duijm-de Carpentier, C.J. van de Velde, M. Kleijn, C. Dreezen, A. Menicucci, L. van’t Veer, W. Audeh
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623001340
_version_ 1797869938513281024
author G.-J. Liefers
E. Meershoek-Klein Kranenbarg
M. Duijm-de Carpentier
C.J. van de Velde
M. Kleijn
C. Dreezen
A. Menicucci
L. van’t Veer
W. Audeh
author_facet G.-J. Liefers
E. Meershoek-Klein Kranenbarg
M. Duijm-de Carpentier
C.J. van de Velde
M. Kleijn
C. Dreezen
A. Menicucci
L. van’t Veer
W. Audeh
author_sort G.-J. Liefers
collection DOAJ
first_indexed 2024-04-10T00:19:19Z
format Article
id doaj.art-ec304695045f4824948dd170300c4127
institution Directory Open Access Journal
issn 1532-3080
language English
last_indexed 2024-04-10T00:19:19Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Breast
spelling doaj.art-ec304695045f4824948dd170300c41272023-03-16T05:01:53ZengElsevierBreast1532-30802023-03-0168S21P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse eventsG.-J. LiefersE. Meershoek-Klein KranenbargM. Duijm-de CarpentierC.J. van de VeldeM. KleijnC. DreezenA. MenicucciL. van’t VeerW. Audehhttp://www.sciencedirect.com/science/article/pii/S0960977623001340
spellingShingle G.-J. Liefers
E. Meershoek-Klein Kranenbarg
M. Duijm-de Carpentier
C.J. van de Velde
M. Kleijn
C. Dreezen
A. Menicucci
L. van’t Veer
W. Audeh
P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
Breast
title P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
title_full P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
title_fullStr P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
title_full_unstemmed P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
title_short P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
title_sort p015 breast cancer patient selection for extended endocrine therapy in the ideal trial by the 70 gene mammaprint test can prevent overtreatment and associated adverse events
url http://www.sciencedirect.com/science/article/pii/S0960977623001340
work_keys_str_mv AT gjliefers p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT emeershoekkleinkranenbarg p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT mduijmdecarpentier p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT cjvandevelde p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT mkleijn p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT cdreezen p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT amenicucci p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT lvantveer p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents
AT waudeh p015breastcancerpatientselectionforextendedendocrinetherapyintheidealtrialbythe70genemammaprinttestcanpreventovertreatmentandassociatedadverseevents